Andrzej Pluta
Brzozow, PK, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: January 14, 2022
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 28, 2020
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study.
Journal: Anticancer research
Published: May 17, 2020
Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: August 30, 2018
1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
Journal: Leukemia & lymphoma
Published: April 14, 2012
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Journal: Hematological oncology
Published: February 20, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026